Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ 9-tetrahydrocannabinol administration

Clinical Chemistry

Volumn 57, Issue 11, 2011, Pages 1597-1606

  Milman, Garry ^a   Schwope, David M ^a   Schwilke, Eugene W ^a,b   Darwin, William D ^a   Kelly, Deanna L ^c   Goodwin, Robert S ^a   Gorelick, David A ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b AIT Laboratories   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; DRONABINOL;

ADULT; ARTICLE; CANNABIS SMOKING; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG DOSE ESCALATION; HUMAN; LIMIT OF QUANTITATION; MALE; MASS FRAGMENTOGRAPHY; ORAL FLUID TESTING; PATIENT MONITORING; QUANTITATIVE ANALYSIS; RELIABILITY;

ADOLESCENT; ADULT; FEASIBILITY STUDIES; HUMANS; MALE; PLASMA; SALIVA; SELF ADMINISTRATION; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; TIME FACTORS; YOUNG ADULT;

CANNABIS;

EID: 80055088857     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.169490     Document Type: Article

References (40)

1. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int 2005;150:165-73. (Pubitemid 41583219)
2. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem 2009;55:1910-31.
3. 9- tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 2004;28:394-9.
4. Huestis MA, ElSohly M, Nebro W, Barnes A, Gustafson RA, Smith ML. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations. Ther Drug Monit 2006;28:540-4. (Pubitemid 44181488)
5. Cone EJ, Johnson RE, Paul BD, Mell LD, Mitchell J. Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion. J Anal Toxicol 1988;12:169-75.
6. Leson G, Pless P, Grotenhermen F, Kalant H, ElSohly MA. Evaluating the impact of hemp food consumption on workplace drug tests. J Anal Toxicol 2001;25:691-8. (Pubitemid 33095889)
7. Voth EA, Schwartz RH. Medicinal applications of delta-9- tetrahydrocannabinol and marijuana. Ann Intern Med 1997;126:791-8. (Pubitemid 27209646)
8. Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001;56:1059-68. (Pubitemid 33039932)
9. Lemberger L, Weiss JL, Watanabe AM, Galanter LM, Wyatt RJ, Cardon PV. Delta-9-tetrahydrocannabinol temporal correlation of the psychologic effects and blood levels after various routes of administration. N Engl J Med 1972;286:685-8.
10. Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol 2006;105:1-25.
11. Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 18:1122-31.
12. Perez-Reyes M. Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol. In: Chiang CN, Hawks RL, eds. Research findings on smoking of abused substances. Rockville (MD): National Institute on Drug Abuse; 1990. p 42-62. NIDA research monograph 99.
13. Huestis MA, Cone EJ. Alternative testing matrices. In: Karch SB, ed. Drug abuse handbook. Boca Raton (FL): CRC Press; 1998. p 799-857.
14. 9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol 2006;30:409-12.
15. Day D, Kuntz DJ, Feldman M, Presley L. Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol 2006;30:645-50. (Pubitemid 44913015)
16. Milman G, Barnes AJ, Lowe RH, Huestis MA. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 2010;1217:1513-21.
17. Sachs H, Dressler U. Detection of THCCOOH in hair by MSD-NCI after HPLC clean-up. Forensic Sci Int 2000;107:239-47. (Pubitemid 30019295)
18. Kintz P, Cirimele V, Mangin P. Testing human hair for cannabis. II. Identification of THC-COOH by GC-MS-NCI as a unique proof. J Forensic Sci 1995;40:619-22.
19. Davis KH, McDaniel IA, Cadwell LW, Moody PL. Some smoking characteristics of marijuana cigarettes. In: Agurell S, Dewey WL, Willette RE, eds. The cannabinoids: chemical, pharmacologic, and therapeutic aspects. Orlando, FL: Academic Press; 1984. p 97-109.
20. 9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 2007;31:288-93.
21. 9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J Anal Toxicol 2010;34:216-21.
22. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, et al. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem 2010;56:1261-9.
23. McCallum NK, Eastwood ME. In vivo binding of delta 1-tetrahydrocannabinol and cannabinol to rat serum proteins. J Pharm Pharmacol 1978;30:384-6. (Pubitemid 8350937)
24. Schwilke EW, Karschner EL, Lowe RH, Gordon AM, Cadet JL, Herning R, Huestis MA. Intra- and inter-subject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin Chem 2009;55:1188-95.
25. Department of Health and Human Services. Mandatory guidelines for federal workplace drug testing. Fed Regist 2008;73:71858-907.
26. 9- tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 2007;1163:318-27.
27. 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma. J Anal Toxicol 1984;8:202-4.
28. Coulter C, Miller E, Moore C, Merves ML, Goldberger BA, Thombs DL, et al. Stability of tetrahydrocannabinol (THC) in oral fluid over a nine month period [Abstract]. Society of Forensic Toxicology Annual Conference, Phoenix, Arizona, October 2008. P19.
29. 9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006;85:114-22.
30. Wille SMR, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit 2009;31:511-9.
31. 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem 2009;55:2180-9.
32. Samyn N, van Haeren C. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Legal Med 2000;113:150-4. (Pubitemid 30339652)
33. 9-tetrahydrocannabinol, 11-hydroxy- THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol 2009;33:469-77.
34. Brenneisen R, Egli A, ElSohly MA, Henn V, Spiess Y. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Int J Clin Pharmacol Ther 1996;34:446-52. (Pubitemid 26341135)
35. 9- tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids. Ther Drug Monit 2006;28:545-51.
36. 9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol 2006;30:413-8.
37. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 1992;16:276-82.
38. Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 1983;34:352-63. (Pubitemid 13006304)
39. 9- tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Anal Bioanal Chem 2010;397:603-11.
40. Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J Anal Toxicol 2005;29:782-9. (Pubitemid 41803377)